In addition, a comprehensive understanding of the MyD88 pathway’s contribution to the regenerative response will determine whether targeting a molecule of the innate immune system could be considered as a treatment target to limit pathogenesis in cardiovascular diseases. Here, MYD88 is linked to cardiovascular disorder.